Accustem Sciences Inc. (ACUT)

Market Cap	3.13M
Revenue (ttm)	n/a
Net Income (ttm)	-2.05M
Shares Out	11.35M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	0.276
Previous Close	0.276
Day's Range	0.276 - 0.276
52-Week Range	0.271 - 1.950
Beta	2.98
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ACUT

AccuStem Sciences, Inc., an early-stage life sciences company, focuses on developing and commercializing products for the treatment and management of various cancers. The company's genomics-based personalized medicine business primarily focuses on breast and lung cancer patients. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2020
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUT